Pharmacologic management of weight regain following bariatric surgery. Academic Article uri icon

Overview

abstract

  • While bariatric surgery restults in significant long-term weight loss for most patients with obesity, post-surgical weight gain affects a considerable percentage of patients to varying degrees of severity. Furthermore, a small but significant percentage of patients experience inadequate post-surgical weight loss. Although many studies have examined the role of anti-obesity medications to address post-operative weight regain, an evidence-based consensus has not yet been achieved because of the heterogeneity of populations studied and the studies themselves. Observational studies in the post-bariatric surgery population consistently demonstrate the benefit of medical weight management after bariatric surgery, with most evidence highlighting liraglutide, topiramate, and phentermine/topiramate. New anti-obesity medications are anticipated to be helpful for post-surgical weight optimization given their efficacy in the non-surgical population.

publication date

  • January 9, 2023

Research

keywords

  • Anti-Obesity Agents
  • Bariatric Surgery
  • Obesity, Morbid

Identity

PubMed Central ID

  • PMC9868802

Scopus Document Identifier

  • 85090484406

Digital Object Identifier (DOI)

  • 10.1016/j.gie.2020.05.028

PubMed ID

  • 36699042

Additional Document Info

volume

  • 13